Washington, DC - An independent data and safety monitoring board (DSMB) overseeing the Phase 3 trial of the investigational COVID-19 vaccine known as mRNA-1273 reviewed trial data and shared its interim analysis with the trial oversight group on Nov. 15, 2020. This interim review of the data suggests that the vaccine is safe and effective at preventing symptomatic COVID-19 in adults. The interim analysis comprised 95 cases of symptomatic COVID-19 among volunteers.

McLean, Virginia - Remarks by Vice President Pence at the Council for National Policy Meeting:

Washington, DC - We, the Heads of State/Government of Member States of the Association of Southeast Asian Nations (ASEAN) and the United States of America, met via videoconference, on 14 November 2020, under Viet Nam’s 2020 ASEAN Chairmanship, on the occasion of the 8th ASEAN-U.S. Summit;

Washington, DC - Remarks by President Trump During an Update on Operation Warp Speed:

Washington, DC - Friday, President Donald J. Trump announced his intent to nominate:

Sacramento, California - Members of the Special Committee on Climate Change received a briefing recently on the California Healthy Soils program.